Skip to main content
  • Careers
  • Contact
  • en   it

Navigazione principale

  • About us
  • GMP Solutions
    • Our services
    • Viral Vector
    • Genetically Modified Cells
    • Facilities
  • PIPELINE
    • Our products
    • CAR-T platform
    • CAR-NK
  • Investors
  • Governance
  • News & Events

Navigazione principale

  • About us
  • GMP Solutions
    • Our services
    • Viral Vector
    • Genetically Modified Cells
    • Facilities
  • PIPELINE
    • Our products
    • CAR-T platform
    • CAR-NK
  • Investors
  • Governance
  • News & Events

MolMed is now part of AGC Biologics

Learn more

AGC Biologics

Investors

Notices
Notices ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

26 March, 2020 - 11:24

Notice of Shareholders meeting April 27 2020

DOWNLOAD

19 March, 2019 - 12:02

Notice of ordinary shareholders’ meeting April 30, 2019

DOWNLOAD

24 September, 2018 - 12:04

Notice of Ordinary and Extraordinary Shareholders Meeting October 25 2018

DOWNLOAD

12 March, 2018 - 12:05

Notice of ordinary meeting April 12, 2018

DOWNLOAD

8 March, 2017 - 12:06

Notice of ordinary shareholders' meeting April 10, 2017

DOWNLOAD

7 October, 2016 - 12:08

Notice of ordinary and extraordinary shareholders' meeting November 7 2016

DOWNLOAD

10 November, 2015 - 12:09

Notice of ordinary shareholders' meeting December 11 2015

DOWNLOAD

1 August, 2014 - 17:32

Notice of ordinary and extraordinary Shareholders' Meeting September 8 2014

DOWNLOAD

14 May, 2014 - 18:16

Financial report at 31 march 2014 (in Italian)

DOWNLOAD

29 March, 2014 - 18:26

Notice of Offering with pre-emptive rights (in Italian)

DOWNLOAD

12 November, 2013 - 12:14

Notice of filing of financial report at 30 september 2013

DOWNLOAD

Subscribe to press releases

By subscribing to this newsletter, you confirm that you have read the Privacy Policy and agree to receive MolMed's press releases

Contacts

Investor Relations & Communication Department
Telefono: +39 02 21277.321
E-mail: investor.relations@molmed.com

Investors

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations. 
In addition, the "work with us" section is still active, while the contact details are no longer accessible.

Leading the way in Cell and Gene therapy

MolMed S.p.A.
Via Olgettina, 58
20132 Milano, Italy
+39 0221277.1
info@molmed.com
Privacy & Cookie Policy

About us

About us ▾

aboutus

  • Business model
  • Our Team
  • Scientific advisory board
  • Hystory
  • Careers

Pipeline

Pipeline ▾

pipeline

  • Our products
  • CAR-T platform
  • CAR-NK

GMP Solutions

GMP Solutions ▾

GMP Solutions footer ENG

  • Our services
  • Viral Vectors
  • Genetically Modified Cells
  • Facilities

Investors

Investors ▾

Investors

  • Stock informations
  • Presentations
  • Notices
  • Events
  • Financial Calendar

Governance

Governance ▾

Governance

  • Corporate governance model
  • Corporate governance rules
  • Business ethics
  • Corporate governance reports

News & Events

News ▾

News

  • News & Events
MolMed S.p.A. Via Olgettina, 58 - 20132 Milano, Italia | Tel. +39 0221277.1 - Fax +39 02 21277.325 | info@molmed.com - www.molmed.com
Capitale Sociale € 21.819.020,83 i.v. - REA n.1506630 - N. iscrizione Reg. Imprese di Milano - C. F. e P. IVA 11887610159